Roger Medel M.D., Chief Executive Officer at MEDNAX, INC. (MD), sold 169,845 shares at $62.52 ($10.6M) on 2014-11-03, disclosed to the SEC on 2014-11-05.
Scheduled sale ($10.6M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.52 | 10,881 | $680K | 6.4% |
| 2 | $62.52 | 15,052 | $941K | 8.9% |
| 3 | $62.61 | 143,912 | $9.0M | 84.7% |
| Total | $62.60 avg | 169,845 | $10.6M | 100% |
| Filing → |
| MD | SELL | 2022-01-04 | $5.1M | — | Filing → |
| MD | SELL | 2021-12-30 | $2.5M | — | Filing → |
| MD | SELL | 2021-12-29 | $6.7M | — | Filing → |